Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

BUY
$253.3 - $285.89 $8,865 - $10,006
35 Added 0.77%
4,590 $1.18 Million
Q1 2023

May 04, 2023

BUY
$256.56 - $292.34 $1.17 Million - $1.33 Million
4,555 New
4,555 $1.27 Million
Q4 2021

Feb 14, 2022

SELL
$223.92 - $287.77 $849,776 - $1.09 Million
-3,795 Closed
0 $0
Q3 2021

Nov 03, 2021

BUY
$282.99 - $369.05 $8,489 - $11,071
30 Added 0.8%
3,795 $1.07 Million
Q2 2021

Aug 03, 2021

BUY
$259.0 - $414.71 $20,720 - $33,176
80 Added 2.17%
3,765 $1.3 Million
Q1 2021

May 06, 2021

BUY
$242.95 - $284.63 $102,039 - $119,544
420 Added 12.86%
3,685 $1.03 Million
Q4 2020

Feb 11, 2021

BUY
$236.26 - $355.63 $386,285 - $581,455
1,635 Added 100.31%
3,265 $799,000
Q3 2020

Oct 28, 2020

BUY
$264.77 - $305.71 $10,590 - $12,228
40 Added 2.52%
1,630 $462,000
Q2 2020

Aug 07, 2020

BUY
$258.66 - $342.55 $12,933 - $17,127
50 Added 3.25%
1,590 $425,000
Q1 2020

Apr 28, 2020

BUY
$268.85 - $341.04 $414,029 - $525,201
1,540 New
1,540 $487,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $20.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Estate Counselors, LLC Portfolio

Follow Estate Counselors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Estate Counselors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Estate Counselors, LLC with notifications on news.